1. Comparative evaluation of nm23 and p16 expression as biomarkers of high-risk human papillomavirus infection and cervical intraepithelial neoplasia 2+ lesions of the uterine cervix
- Author
-
Luciano Mariani, Irene Terrenato, Francesca Rollo, Giuseppe Vocaturo, Ferdinando Marandino, Mariantonia Carosi, Maria Benevolo, Amina Vocaturo, Paola Muti, Marcella Mottolese, and Livia Ronchetti
- Subjects
medicine.medical_specialty ,Pathology ,Histology ,Tumor suppressor gene ,Anatomical pathology ,General Medicine ,Biology ,Cervical intraepithelial neoplasia ,medicine.disease ,female genital diseases and pregnancy complications ,Virus ,Pathology and Forensic Medicine ,law.invention ,law ,Genotype ,medicine ,Biomarker (medicine) ,Immunohistochemistry ,Polymerase chain reaction - Abstract
Benevolo M, Terrenato I, Mottolese M, Marandino F, Muti P, Carosi M, Rollo F, Ronchetti L, Mariani L, Vocaturo G & Vocaturo A (2010) Histopathology57, 580โ586 Comparative evaluation of nm23 and p16 expression as biomarkers of high-risk human papillomavirus infection and cervical intraepithelial neoplasia 2+ lesions of the uterine cervix Aims: To investigate the clinical role of nm23 expression in identifying both high-risk human papillomavirus (HR-HPV) and high-grade cervical lesions or carcinomas [cervical intraepithelial neoplasia 2+ (CIN2+)], and to compare it with p16 overexpression, as this latter biomarker has already been reported widely in HR-HPV infected cervical lesions. Methods and results: Immunohistochemical evaluation of nm23 and p16 in 143 cervical biopsy specimens including negative, low- and high-grade lesions and squamous carcinomas (SC). HR-HPV testing by Digene hybrid capture 2 (HC2) and polymerase chain reaction (PCR) on the cervico-vaginal samples of the same patients. In detecting CIN2+, p16 was significantly more sensitive and specific than nm23 (96.3% versus 81.8% and 66% versus 36.4%, respectively, both P
- Published
- 2010
- Full Text
- View/download PDF